Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.65 |
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20380836 | 1.00 | FAAH (0.65) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL10607338 | 0.98 | FAAH (0.61) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL23344139 | 0.94 | FAAH (0.68) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL20714965 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL15003766 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL30970182 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL12250891 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL20909276 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL30970230 | 0.94 | FAAH (0.68) | FAAHCASP2DNM1NAAAEPHX2 | |
| SCHEMBL15369060 | 0.94 | CASP2 (0.71) | FAAHCASP2DNM1NAAAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017177326-A1 | TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2017-10-19 | — | — | WO | disclosed |